Uncovering distinct genomic and molecular signatures in triple-negative inflammatory breast cancer
This study is the most comprehensive genomic and transcriptomic analysis of triple-negative inflammatory breast cancer (TN-IBC) patient samples, uncovering unique genetic and immune characteristics. These findings aim to advance the diagnosis and treatment of this aggressive disease.